Disclaimer

Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.

US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.
Videos

Aortic Regurgitation in 2022 - Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs

James M. McCabe, Vinod H. Thourani, Nadira Hamid, Ravi Ramana and Mark J. Russo discuss JenaValve’s Trilogy System as a solution for severe AR patients at the “Aortic Regurgitation in 2022 – Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs” symposium.

Latest News

View All
Press
JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
March 28, 2024
JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
Read More
Press
JenaValve’s Trilogy THV System Highlighted at CRT 2024
March 19, 2024
JenaValve’s Trilogy THV System Highlighted at CRT 2024
Read More
Press
JenaValve Announces Partnership with the ASE to Advance Detection and Diagnosis of AR
November 16, 2023
JenaValve Announces Partnership with the ASE to Advance Detection and Diagnosis of AR
Read More